Teva Reports Third Quarter 2020 Financial Results | Business Wire
Annual Report 2018 - Canada.ca
Annual Report and Financial Statements
Annual report and audited financial statements
Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease